Indication
Post-dural Puncture Headache
1 clinical trial
2 products
Clinical trial
Evaluation of the Effectiveness and Tolerance of Tetracosactide Synacthen® in the Treatment of Post Dural Puncture Headaches (ESYBRECHE)Status: Terminated, Estimated PCD: 2022-11-01
Product
TetracosactideProduct
Placebo Saline